RegulatorySpine

Aegis Spine, Inc., an innovative subsidiary of L&K BioMed, is proud and eager to announce FDA 510(k) clearance of the new AccelFix Expandable Cage System

Aegis Spine, Inc., an innovative subsidiary of L&K BioMed, is proud and eager to announce FDA 510(k) clearance of the new AccelFix Expandable Cage System – a sterile-packaged, all-encompassing family of expandable interbody devices, which was launched this month at NASS 2019 in Chicago, Illinois.

The AccelFix Expandable Cage System includes expandable interbody solutions from TLIF/PLIF cages (AccelFix-XT), an expandable lateral interbody (AccelFix-XL), and a ground-breaking, Anterior-to-Psoas expandable interbody specially contoured to avoid the contralateral nerve root (Accelfix-XTP).

The launch of the new expandable interbody devices will be added to a wide range of spinal product portfolio which includes AccelFix 5.5 Rod Spinal Fixation System which earned a FDA clearance earlier this year.

Print Friendly, PDF & Email
Tags

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button
Close